Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
0.00%
)
US TECH 100
23,588.80
(
-0.87%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
107.55
(
0.91%
)
Bitcoin
69,287.66
(
-2.74%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 73786

Sunday, 03/01/2009 1:18:59 AM

Sunday, March 01, 2009 1:18:59 AM

Post# of 257257
CEPH - After getting an option to buy Ception Therapeutics for its humanized IL-5 Mab - reslizumab and acquiring rights to Lupuzor from ImmunPharma, CEPH makes another move, this time in the anti-TNF antibody arena.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now